NanoString Technologies Profit Margin 2011-2019 | NSTG

Current and historical gross margin, operating margin and net profit margin for NanoString Technologies (NSTG) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. NanoString Technologies net profit margin as of September 30, 2019 is -72.3%.
NanoString Technologies Annual Profit Margins
NanoString Technologies Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.171B $0.107B
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $143.473B 25.11
Medtronic (MDT) Ireland $142.281B 19.13
Stryker (SYK) United States $75.537B 24.41
Boston Scientific (BSX) United States $54.996B 24.77
Baxter (BAX) United States $44.434B 26.94
Lonza Group Ag (LZAGY) Switzerland $30.852B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $30.514B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.251B 18.62
Coloplast (CLPBY) Denmark $29.138B 44.97
Terumo (TRUMY) Japan $24.711B 30.84
ResMed (RMD) United States $23.995B 41.69
Smith & Nephew SNATS (SNN) United Kingdom $20.792B 0.00
Sunny Optical Technology (SNPTF) China $18.060B 0.00
Insulet (PODD) United States $11.129B 692.35
Bio-Rad Laboratories (BIO) United States $11.046B 51.61
Perrigo (PRGO) Ireland $8.258B 15.40
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Canopy Growth (CGC) Canada $6.924B 0.00
Hill-Rom Holdings (HRC) United States $6.809B 19.58
DiaSorin S.p.A (DSRLF) Italy $6.446B 0.00
Haemonetics (HAE) United States $5.461B 33.61
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.224B 27.54
Envista Holdings (NVST) United States $4.210B 0.00
NuVasive (NUVA) United States $3.603B 27.86
Neogen (NEOG) United States $3.585B 59.66
Quidel (QDEL) United States $3.390B 29.76
Agios Pharmaceuticals (AGIO) United States $3.314B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.305B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.193B 0.00
National Vision Holdings (EYE) United States $3.054B 52.16
Aurora Cannabis (ACB) Canada $1.765B 0.00
AtriCure (ATRC) United States $1.600B 0.00
TG Therapeutics (TGTX) United States $1.381B 0.00
Cardiovascular Systems (CSII) United States $1.343B 0.00
InMode (INMD) Israel $1.096B 0.00
Phibro Animal Health (PAHC) United States $1.049B 20.74
Aphria (APHA) $1.020B 0.00
PetIQ (PETQ) United States $0.926B 22.58
VAREX IMAGING (VREX) United States $0.917B 19.06
Cerus (CERS) United States $0.851B 0.00
Quanterix (QTRX) United States $0.695B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 25.49
DFB Healthcare Acquisitions (AHCO) United States $0.653B 124.62
Lantheus Holdings (LNTH) United States $0.640B 14.55
Omeros (OMER) United States $0.633B 0.00
LeMaitre Vascular (LMAT) United States $0.590B 33.51
MacroGenics (MGNX) United States $0.588B 0.00
Surmodics (SRDX) United States $0.494B 56.80
Zynex (ZYXI) United States $0.414B 46.78
Owens & Minor (OMI) United States $0.412B 15.23
Organigram Holdings (OGI) Canada $0.384B 0.00
OraSure Technologies (OSUR) United States $0.374B 46.62
HEXO (HEXO) $0.352B 0.00
Utah Medical Products (UTMD) United States $0.349B 24.84
Meridian Bioscience (VIVO) United States $0.320B 12.88
Evolus (EOLS) United States $0.305B 0.00
BioLife Solutions (BLFS) United States $0.303B 123.42
Repro-Med Systems (KRMD) United States $0.278B 176.00
Female Health (VERU) United States $0.277B 0.00
Bovie Medical (APYX) United States $0.238B 0.00
InfuSystems Holdings (INFU) United States $0.206B 1039.00
Rockwell Medical (RMTI) United States $0.203B 0.00
Vapotherm (VAPO) United States $0.203B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.201B 0.00
Cytosorbents (CTSO) United States $0.183B 0.00
Viemed Healthcare (VMD) United States $0.183B 19.24
United Health Products (UEEC) United States $0.180B 0.00
Liberty Health Sciences (LHSIF) Canada $0.137B 0.00
Fonar (FONR) United States $0.129B 9.39
Green Organic Dutchman Holdings (TGODF) Canada $0.128B 0.00
Chimerix (CMRX) United States $0.115B 0.00
MTech Acquisition (KERN) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.084B 0.00
Surface Oncology (SURF) United States $0.078B 0.00
United-Guardian (UG) United States $0.077B 19.36
Chembio Diagnostics (CEMI) United States $0.067B 0.00
Nephros (NEPH) United States $0.067B 0.00
FSD PHARMA INC (HUGE) Canada $0.042B 0.00
NF Energy Saving (BIMI) China $0.037B 0.00
ImmuCell (ICCC) United States $0.035B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Myomo (MYO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00